Home Case Studies PT. Holi Pharma Collaboration—the key to growth
PT. Holi Pharma enlists IBM Consulting to successfully deploy a modernized system using SAP, leading to a surge in overall company growth
Pharmacy storage room stocked with medicine
Inconsistencies and lack of data

Indonesia’s top pharmaceutical company, PT. Holi Pharma—part of PYFA Group—was facing multiple roadblocks when it came to operating margins and revenue growth. Inconsistencies and lack of data across the organization led to decision-making and implementation bottlenecks. Holi Pharma looked to modernize its IT systems and processes to comply with industry standards. The pharmaceutical company also hoped to improve operating margins and grow revenue.

Working in tandem with AWS

A robust enterprise foundation was crucial for integrating and streamlining business processes and optimizing productivity across Holi Pharma. The company needed to apply transformational technologies and services while harmonizing processes, data and reporting across all departments to stay ahead of competitors and continue its growth. That’s where IBM came in alongside Amazon Web Services (AWS), and the two technology giants began to chip away at the transformation barriers Holi Pharma was encountering. IBM Consulting® helped the company successfully deploy RISE with SAP (link resides outside of ibm.com) to move its mission-critical ERP workloads and processes to AWS cloud.

“With the ever-changing healthcare landscape, we sought expert guidance,” explains Lioe Julius, Head of IT at PYFA Group. “We saw IBM as the major consultant in Indonesia for SAP, their platinum partner. Having experience deploying SAP across various sectors, particularly healthcare, IBM was ideally suited to lead our fast-paced project.”

Julius continues: “By working together with the Indonesian team and tapping into IBM’s internal resources, we can guarantee we’re following best practices and have a wider network of expertise to address any challenges that may arise.”

Julius explains that the migration process ran smoothly. IBM had established dates for downtime with the Holi Pharma team. Moving into AWS was effectively done over three Saturday nights. While there were specific windows of operating downtime—12 hours—IBM made it very clear what preparations were to be done ahead of the planned migration.

7–10 days to complete month-end closings, instead of months
The ability to generate reports and insights on demand allows us to stay ahead of market changes and make strategic decisions quickly, paving the way for our continued growth and expansion. Lioe Julius Head of IT PYFA Group
Transformational technologies and harmonized processes

Enabled by RISE with SAP, the combined expertise from the partnership with IBM and AWS has laid a foundation for Holi Pharma to accelerate its transformation. The company has begun ramping up its SAP S/4HANA modernization journey and can share data efficiently among business units, providing decision-makers with precise operational insights. Processes like month-end closings and production planning now occur much faster—closings that once required weeks or longer now finish within 7–10 days—and employees can focus more time on high-value analysis.

By integrating RISE with SAP, Holi Pharma can create a detailed profitability analyses using modules at the segment and product levels. The adaptability within the high-performance computing and storage systems enables IBM and SAP to deploy the RISE with SAP landscape faster, resulting in a much shorter project timeline for the pharmaceutical company. The new integration can also increase Holi Pharma’s competitiveness and help with its profitability.

Julius credits the new system, saying: “Improved data traceability through our new system empowers production planning for efficient collaboration with marketing. Additionally, our AWS infrastructure positions us for strategic growth by enabling comprehensive data analysis and user-driven innovation.”

Holi Pharma logo
About PT. Holi Pharma

A subsidiary of PYFA Group, Holi Pharma (link resides outside of ibm.com) is a pharmaceutical company in Cimahi, West Java, Indonesia. The company produces a wide range of medicines from various therapeutic areas in the form of syrups, tablets/caplets, capsules, semi-solid and liquid external drugs. Holi Pharma has more than 150 SKUs of products, including a combination of generic and branded products that include drugs, antibiotics, vitamins and supplements.

Take the next step

To learn more about the IBM solutions featured in this story, please contact your IBM representative or IBM Business Partner.

 

View more case studies Contact IBM
Legal

© Copyright IBM Corporation 2024. IBM Corporation, New Orchard Road, Armonk, NY 10504

Produced in the United States of America, May 2024.

IBM, the IBM logo, ibm.com, and IBM Consulting are trademarks or registered trademarks of International Business Machines Corporation, in the United States and/or other countries. Other product and service names might be trademarks of IBM or other companies. A current list of IBM trademarks is available on A current list of IBM trademarks is available on ibm.com/legal/copyright-trademark.

This document is current as of the initial date of publication and may be changed by IBM at any time. Not all offerings are available in every country in which IBM operates.

THE INFORMATION IN THIS DOCUMENT IS PROVIDED “AS IS” WITHOUT ANY WARRANTY, EXPRESS OR IMPLIED, INCLUDING WITHOUT ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND ANY WARRANTY OR CONDITION OF NON-INFRINGEMENT. IBM products are warranted according to the terms and conditions of the agreements under which they are provided.

© 2024 SAP SE. All rights reserved. SAP, R/3, SAP NetWeaver, Duet, PartnerEdge, ByDesign, SAP BusinessObjects Explorer, StreamWork, SAP HANA, and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. These materials are provided by SAP SE or an SAP affiliate company for informational purposes only, without representation or warranty of any kind, and SAP SE or its affiliated companies shall not be liable for errors or omissions with respect to the materials. This document, or any related presentation, and SAP SE’s or its affiliated companies’ strategy and possible future developments, products, and/or platform directions and functionality are all subject to change and may be changed by SAP SE or its affiliated companies at any time for any reason without notice.